Pierre Fabre and its partner Array BioPharma announce interim analysis results from the BEACON CRC Trial of encorafenib + binimetinib + cetuximab for the treatment of BRAFV600E-mutant metastatic colorectal cancer | Business Wire
Décès de Pierre Fabre, la succession s'annonce difficile
LABORATORY CORPORATION OF AMERICA HOLDINGS 2022 NPS
Pierre Fabre Dermo-Cosmétique investit 16 millions dans l'extension de son usine d'Avène
In Guinea and Togo, Autocratic Leaders Are Rolling Back Democracy to Cling to Power
Cetuximab in combination with platinum-based chemotherapy or radiotherapy in recurent and/or metastatic SCCHN in a non-selected
PIERRE FABRE MEDICAMENT
Pierre Fabre forms connected underwear collaboration | Fierce Biotech
Positive Phase III data for Pierre Fabre and Array BioPharma
Courtney Haas - Pharmaceutical Representative - Pierre Fabre Group | LinkedIn
Décès de Pierre Fabre : qui dirigera l'empire ?
FOUAD KERBAGE - Global Medical Advisor for Lung Cancer - Pierre Fabre Group | LinkedIn
PIERRE FABRE - STATION NEXT
Christophe DURAND, new CEO at Cenexi - Cenexi
PharmaShots Interview: Pierre Fabre' Roberta Valenti Shares Insights on Nerlynx (neratinib) for the Treatment of HER2 Early Breast Cancer
Les Laboratoires Pierre Fabre dévoilent leur nouvelle gouvernance
Vera Seeks to Initiate P-III Clinical Trial of Atacicept for the Treatment of Lupus Nephritis
Khaled Laouiti :«Pierre Fabre Tunisie, une plateforme d'export vers l'Afrique sub-saharienne.» - Entreprises Magazine
Pierre Fabre remporte le BFM Award 2021 de la conquête à l'international
